420 related articles for article (PubMed ID: 21942657)
1. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
Socolov D; Blidaru I; Tamba B; Miron N; Boiculese L; Socolov R
Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):480-7. PubMed ID: 21942657
[TBL] [Abstract][Full Text] [Related]
2. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
3. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
4. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
5. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
[TBL] [Abstract][Full Text] [Related]
6. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
7. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):74-9. PubMed ID: 12039094
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Cihangir U; Ebru A; Murat E; Levent Y
Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
[TBL] [Abstract][Full Text] [Related]
9. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.
Kriplani A; Awasthi D; Kulshrestha V; Agarwal N
Int J Gynaecol Obstet; 2012 Jan; 116(1):35-8. PubMed ID: 21959070
[TBL] [Abstract][Full Text] [Related]
11. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
[TBL] [Abstract][Full Text] [Related]
12. The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia.
Mercorio F; De Simone R; Di Spiezio Sardo A; Cerrota G; Bifulco G; Vanacore F; Nappi C
Contraception; 2003 Apr; 67(4):277-80. PubMed ID: 12684148
[TBL] [Abstract][Full Text] [Related]
13. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine device use among women with uterine fibroids: a systematic review.
Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
Kriplani A; Singh BM; Lal S; Agarwal N
Int J Gynaecol Obstet; 2007 Jun; 97(3):190-4. PubMed ID: 17382331
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma.
Senol T; Kahramanoglu I; Dogan Y; Baktiroglu M; Karateke A; Suer N
Clin Exp Obstet Gynecol; 2015; 42(2):224-7. PubMed ID: 26054124
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Murat Naki M; Tekcan C; Ozcan N; Cebi M
Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
[TBL] [Abstract][Full Text] [Related]
19. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
Heikinheimo O; Gemzell-Danielsson K
Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
Shaw V; Vandal AC; Coomarasamy C; Ekeroma AJ
Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):619-623. PubMed ID: 27696346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
